Dachaigh › Tiotalan dreuchd › Validation Engineer III
Validation Engineer III: Tuarastalan H-1B
Chleachd 46 iarrtasan cumhaichean-obrach an tiotal dreuchd Validation Engineer III. Tuarastal bunasach meadhanach $105,000; leth meadhanach $98,405–$118,889.
Luchd-fastaidh
| Neach-obrach | LCAs | Tuarastal meadhanach |
|---|---|---|
| FUJIFILM Diosynth Biotechnologies Texas LLC | 9 | $105,000 |
| Azzur Group DBA, Azzur Consulting LLC | 6 | $111,695 |
| Emd Millipore Corporation | 4 | $107,500 |
| Gilead Sciences, Inc. | 3 | $138,174 |
| Verista Inc (fka Delta Project Management, Inc.) | 2 | $127,348 |
| Thermo Fisher Scientific Inc. | 2 | $97,771 |
| Kashiv BioSciences LLC | 2 | $128,000 |
| AGC Biologics, Inc. | 2 | $99,822 |
| Azzur Group LLC dba Azzur Consulting LLC | 2 | $95,000 |
| Amneal Pharmaceuticals, LLC | 1 | $87,422 |
| Verista, Inc. | 1 | $120,120 |
| SAS Info Inc | 1 | $79,664 |
| Arrowtek Technologies, LLC | 1 | $115,000 |
| PSC Biotech Corporation | 1 | $83,782 |
| Lonza Houston Inc | 1 | $84,656 |
| Genezen MA, Inc. | 1 | $113,629 |
| Ocular Therapeutix, Inc. | 1 | $98,405 |
| Curia Global, Inc. | 1 | $132,351 |
| Anika Therapeutics, Inc. | 1 | $98,405 |
| Rocket Pharmaceuticals, Inc. | 1 | $147,518 |
| KBI Biopharma, Inc. | 1 | $109,741 |
| Exela Pharma Sciences, LLC | 1 | $102,000 |
| Just-Evotec Biologics, Inc. | 1 | $127,000 |
A rèir ìre tuarastail
| Ìre tuarastail | Tuarastal meadhanach |
|---|---|
| Ìre I (innte) | $95,000 |
| Ìre II (càileachail) | $100,548 |
| Ìre III (eòlach) | $105,000 |
| Ìre IV (gu lèir comasach) | $138,174 |
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
A rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 10 | $105,000 |
| FY2024 | 17 | $100,548 |
| FY2025 | 16 | $107,692 |
| FY2026 | 3 | $102,000 |
Bailtean
- College Station, TX8
- Piscataway, NJ3
- Oceanside, CA3
- Jaffrey, NH3
- Bedford, MA3
- Portsmouth, NH2
- Hatboro, PA2
- Bothell, WA2
- Morrisville, NC2
- Cambridge, MA1
- Bryan, TX1
- Sanford, NC1
- Palinville, MA1
- Spokane, WA1
- Newbury Park, CA1
- High Point, NC1
- Houston, TX1
- Waltham, MA1
- Irvine, CA1
- Lexington, MA1
- Burlington, MA1
- La Verne, CA1
- San Diego, CA1
- Cranbury, NJ1
- Raleigh, NC1
- Lenoir, NC1
- Redmond, WA1
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).